TABLE 2.
Occurrence and association of toxins and CFs in ETEC isolates
| Toxin produced | Total no. of isolatesa | CF type(s) produced | No. (%) of isolates |
|---|---|---|---|
| ST | 200 | CFA/I | 48 (24) |
| CS1 + CS3 | 18 (9.0) | ||
| CS2 + CS3 | 22 (11.0) | ||
| CS4 + CS6 | 19 (9.5) | ||
| CS5 + CS6 | 39 (19.5) | ||
| CS6 | 35 (17.5) | ||
| CS7 | 5 (2.5) | ||
| CS14 | 9 (4.5) | ||
| CS12 | 5 (2.5) | ||
| LT and ST | 130 | CFA/I | 39 (30.0) |
| CS1 + CS3 | 16 (12.3) | ||
| CS2 + CS3 | 14 (10.7) | ||
| CS3 | 9 (7.0) | ||
| CS4 + CS6 | 21 (16.0) | ||
| CS7 | 5 (3.8) | ||
| CS14 | 16 (12.3) | ||
| CS12 | 10 (7.7) | ||
| LT | 40 | CS7 | 19 (47.5) |
| CS17 | 11 (27.5) | ||
| CS8 | 10 (25.0) |
a
ETEC isolates of each toxin type positive for the different CFs.